Log In

Investor Relations Update December 31, 2024

Dear Valued Shareholders,

As we approach the new year, we extend our warmest wishes for a healthy, happy, and prosperous 2025. Your continued support and commitment are instrumental to our success, and we are grateful for your partnership.

In adherence to SEC regulations and to uphold the highest standards of transparency and fairness, we have updated our Shareholder Communication Policy, effective December 1, 2024. We encourage you to familiarize yourself with the revised policy, accessible through the following channels:

• Please refer to the attached Health Karma Shareholder Communications Policy document.

• Visit the Investor Relations section of our website at Health Karma Investor Relations. This page is routinely updated with the latest information and insights, so we recommend checking back regularly.

To ensure the confidentiality of material non-public information, we kindly remind all shareholders that direct phone calls or texts to our executives are considered restricted forms of communication. We will not respond to such inquiries to maintain compliance and safeguard information integrity.

Regarding our financial disclosures, we are pleased to inform you that our Form 10-K for 2023 is in the final stages of audit approval and is expected to be filed shortly after the holiday season. Our focus will subsequently shift towards the prompt filing of our 2024 10-Qs.

In closing, we are excited to report that our business pipeline remains robust, and we are optimistic about a highly successful first quarter. We look forward to sharing our progress and achievements with you as we move forward.

Thank you once again for your trust and investment in Health Karma. Should you have any questions or require further assistance, please do not hesitate to contact our Investor Relations team.

Warm regards,

Health Karma Investor Relations Team